Change of Name

Recorded: 2016-06-06 Pages: 9

Assignor

AROG PHARMACEUTICALS, LLC

Executed: 2014-09-13

Assignee

AROG PHARMACEUTICALS, INC.

5420 LBJ FREEWAY, SUITE 410, TWO LINCOLN CENTER, DALLAS, TEXAS, 75240

Covered Property (1)

Crenolanib for Treating FLT3 Mutated Proliferative Disorders

Patent: 9,393,240 →

Application: 14/703,500 →

Publication: US 2015/0238479

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.